Valuation: AstraZeneca PLC

Capitalization 232B 201B 188B 171B 315B 19,934B 357B 2,196B 855B 9,126B 868B 851B 33,363B P/E ratio 2025 *
23.4x
P/E ratio 2026 * 19.4x
Enterprise value 252B 218B 204B 186B 342B 21,679B 388B 2,388B 930B 9,925B 944B 925B 36,282B EV / Sales 2025 *
4.35x
EV / Sales 2026 * 4x
Free-Float
96.62%
Yield 2025 *
2.15%
Yield 2026 * 2.26%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.40%
1 week+1.89%
Current month+2.48%
1 month+7.92%
3 months-7.54%
6 months+4.95%
Current year+4.95%
More quotes
1 week 10,696
Extreme 10696
11,086
1 month 9,932
Extreme 9932
11,086
Current year 9,573.5
Extreme 9573.505
12,208
1 year 9,573.5
Extreme 9573.505
13,388
3 years 9,461
Extreme 9461
13,388
5 years 6,736
Extreme 6736
13,388
10 years 3,680
Extreme 3680
13,388
More quotes
Manager TitleAgeSince
Chief Executive Officer 65 2012-09-30
Director of Finance/CFO 51 2021-07-31
Chief Tech/Sci/R&D Officer - 2023-07-31
Director TitleAgeSince
Director/Board Member 69 1999-04-05
Director/Board Member 65 2012-09-30
Director/Board Member 64 2017-04-26
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.40%+1.89%-11.35%+12.37% 232B
+0.90%+6.43%-7.24%+181.30% 736B
+0.28%+1.34%+8.01%-8.03% 378B
-0.58%+5.27%-47.31%+34.04% 355B
-0.70%+0.66%+14.72%+37.05% 338B
-1.06%+0.56%+9.72%-12.79% 266B
-0.93%+0.08%+3.08%+17.37% 235B
-0.13%+3.47%-36.84%-3.87% 205B
-0.70%+1.68%-1.10%+24.69% 159B
-1.21%+5.10%-11.25%-48.78% 140B
Average -0.45%+2.94%-7.96%+23.34% 304.24B
Weighted average by Cap. -0.19%+3.35%-7.48%+50.87%
See all sector performances

Financials

2025 *2026 *
Net sales 57.83B 50.09B 46.86B 42.61B 78.56B 4,978B 89.16B 548B 214B 2,279B 217B 212B 8,331B 61.18B 53B 49.57B 45.09B 83.11B 5,267B 94.33B 580B 226B 2,411B 229B 225B 8,814B
Net income 9.92B 8.59B 8.04B 7.31B 13.47B 854B 15.29B 94.06B 36.64B 391B 37.2B 36.43B 1,429B 11.95B 10.35B 9.68B 8.8B 16.23B 1,028B 18.42B 113B 44.13B 471B 44.8B 43.88B 1,721B
Net Debt 20.26B 17.55B 16.42B 14.93B 27.53B 1,744B 31.24B 192B 74.85B 799B 75.99B 74.42B 2,919B 12.88B 11.16B 10.43B 9.49B 17.49B 1,109B 19.85B 122B 47.57B 508B 48.3B 47.3B 1,855B
More financial data * Estimated data
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (94.2%). Net sales break down by treatment area between oncology (39.8%), cardiovascular, renal and metabolic diseases (24.4%), respiratory and autoimmune diseases (14.6%), and other (21.2%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (5.8%). Net sales are distributed geographically as follows: the United Kingdom (8.8%), Europe (21.6%), the United States (40.3%), Americas (5.9%) and Africa/Asia/Australia (23.4%).
Employees
94,300
More about the company
Date Price Change Volume
25-06-13 10,986.00 p -0.40% 1,985,957
25-06-12 11,030.00 p +1.14% 1,172,368
25-06-11 10,906.00 p +0.31% 1,482,294
25-06-10 10,872.00 p +0.93% 910,150
25-06-09 10,772.00 p -0.09% 629,958

Delayed Quote London S.E., June 13, 2025 at 11:35 am EDT

More quotes
Trading Rating
Investor Rating
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
149.34USD
Average target price
179.12USD
Spread / Average Target
+19.94%
Consensus

Quarterly revenue - Rate of surprise